Literature DB >> 17307144

Participation of nitric oxide reductase in survival of Pseudomonas aeruginosa in LPS-activated macrophages.

Kohei Kakishima1, Akiko Shiratsuchi, Azuma Taoka, Yoshinobu Nakanishi, Yoshihiro Fukumori.   

Abstract

Nitric oxide (NO) plays a crucial role in the antimicrobial activity of host defense systems. We investigated the function of Pseudomonas aeruginosa NO reductase as a detoxifying enzyme in phagocytes. We found that the growth of the NO reductase-deficient mutant of P. aeruginosa under a microaerobic condition was inhibited by the exogenous NO. Furthermore, the intracellular survival assay within the NO-producing RAW 264.7 macrophages revealed that the wild-type strain survived longer than the NO reductase-deficient mutant. These results suggest that the P. aeruginosa NO reductase may contribute to the intracellular survival by acting as a counter component against the host's defense systems.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17307144     DOI: 10.1016/j.bbrc.2007.02.017

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

Review 1.  Innate immune responses to Pseudomonas aeruginosa infection.

Authors:  Elise G Lavoie; Tamding Wangdi; Barbara I Kazmierczak
Journal:  Microbes Infect       Date:  2011-08-02       Impact factor: 2.700

Review 2.  Nitrate, nitrite and nitric oxide reductases: from the last universal common ancestor to modern bacterial pathogens.

Authors:  Andrés Vázquez-Torres; Andreas J Bäumler
Journal:  Curr Opin Microbiol       Date:  2015-09-29       Impact factor: 7.934

3.  Examination of the Staphylococcus aureus nitric oxide reductase (saNOR) reveals its contribution to modulating intracellular NO levels and cellular respiration.

Authors:  A M Lewis; S S Matzdorf; J L Endres; I H Windham; K W Bayles; K C Rice
Journal:  Mol Microbiol       Date:  2015-03-16       Impact factor: 3.501

4.  Copper response regulator1-dependent and -independent responses of the Chlamydomonas reinhardtii transcriptome to dark anoxia.

Authors:  Anja Hemschemeier; David Casero; Bensheng Liu; Christoph Benning; Matteo Pellegrini; Thomas Happe; Sabeeha S Merchant
Journal:  Plant Cell       Date:  2013-09-06       Impact factor: 11.277

5.  Dynamics of nitric oxide controlled by protein complex in bacterial system.

Authors:  Erina Terasaka; Kenta Yamada; Po-Hung Wang; Kanta Hosokawa; Raika Yamagiwa; Kimi Matsumoto; Shoko Ishii; Takaharu Mori; Kiyoshi Yagi; Hitomi Sawai; Hiroyuki Arai; Hiroshi Sugimoto; Yuji Sugita; Yoshitsugu Shiro; Takehiko Tosha
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-28       Impact factor: 11.205

6.  Nitric oxide production by polymorphonuclear leucocytes in infected cystic fibrosis sputum consumes oxygen.

Authors:  M Kolpen; T Bjarnsholt; C Moser; C R Hansen; L F Rickelt; M Kühl; C Hempel; T Pressler; N Høiby; P Ø Jensen
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

7.  Copper(I)/NO(g) Reductive Coupling Producing a trans-Hyponitrite Bridged Dicopper(II) Complex: Redox Reversal Giving Copper(I)/NO(g) Disproportionation.

Authors:  Gayan B Wijeratne; Shabnam Hematian; Maxime A Siegler; Kenneth D Karlin
Journal:  J Am Chem Soc       Date:  2017-09-12       Impact factor: 15.419

Review 8.  Nitric Oxide-Releasing Macromolecular Scaffolds for Antibacterial Applications.

Authors:  Lei Yang; Evan S Feura; Mona Jasmine R Ahonen; Mark H Schoenfisch
Journal:  Adv Healthc Mater       Date:  2018-05-14       Impact factor: 9.933

9.  The Pseudomonas aeruginosa CreBC two-component system plays a major role in the response to β-lactams, fitness, biofilm growth, and global regulation.

Authors:  Laura Zamorano; Bartolomé Moyà; Carlos Juan; Xavier Mulet; Jesús Blázquez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2014-06-16       Impact factor: 5.191

Review 10.  New challenges in studying nutrition-disease interactions in the developing world.

Authors:  Andrew M Prentice; M Eric Gershwin; Ulrich E Schaible; Gerald T Keusch; Cesar G Victora; Jeffrey I Gordon
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.